Envoy Medical Inc

Análisis de la acción Envoy Medical Inc (COCH)

$7.150

+0.050 (+0.70%)Al cierre

Loading chart…
Máximo
7.240
Apertura
7.050
Precio medio ponderado por volumen
7.10
Volumen
50.48K
Capitalización
44.88M
Mínimo
6.900
Importe
358.20K
EV/EBITDA, TTM
-1.23

Envoy Medical, Inc. is a hearing health company. The Company is engaged in providing medical technologies across the hearing loss spectrum, all designed to shift the paradigm within the hearing industry and bring both providers and patients the hearing devices they require. Its hearing solutions include hearing aids, middle ear implants, bone conduction devices and cochlear implants. The bone conduction hearing device has two components: an external component and a surgically implanted fixture placed in the bone behind the ear. Its bone conduction hearing device offers amplification without ear mold in the ear. Its hearing aids are devices that amplify sound for those with mild to moderate hearing loss. Its Esteem is a fully implanted active middle ear implant designed to improve the hearing of adults diagnosed with moderate to severe sensorineural hearing loss. Cochlear implants are a solution for people with moderate-to-profound sensorineural hearing loss.

Análisis de IA of Envoy Medical Inc (COCH)

Comprar

Envoy Medical Inc is a good buy right now due to its recent performance and positive outlook. The current price is $6.65, which is significantly below the analyst price targets of $2.00 and $2.50, indicating a potential upside. Additionally, the stock has shown a remarkable year-to-date change of +855.87% and a 20-day change of +921.51%, reflecting strong momentum. However, the main risk is the negative earnings per share (EPS) estimate of -0.70 for the upcoming earnings report, which could impact investor sentiment.

Métricas de valoración

El PER previsto actual de Envoy Medical Inc (COCH) es 0.00, frente a su media de 5 años de -1.83.

PER previsto

Sobrevalorado
Media 5A P/E
-1.83
P/E actual
0.00
Sobrevalorada
-0.18
Infravalorada
-3.47

EV/EBITDA previsto

Valor razonable
Media 5A EV/EBITDA
-1.22
EV/EBITDA actual
-1.23
Sobrevalorada
0.67
Infravalorada
-3.10

Precio/ventas previsto

Valor razonable
Media 5A P/S
113.45
P/S actual
201.61
Sobrevalorada
203.65
Infravalorada
23.26

Escenarios de precio de Alphio AI para COCH

Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

A

Alcista

Alcista · 25%COCH

$1.15

Precio del escenario

B

Base

Base · 50%COCH

$1.10

Precio del escenario

B

Bajista

Bajista · 25%COCH

$1.10

Precio del escenario

Cronología de eventos

2026-10-26 (ET)

10:00:00

Envoy Medical Inc Trading Halted

2026-10-23 (ET)

20:00:00

Envoy Medical Inc Trading Halted, News Pending

2026-06-02 (ET)

08:50:00

Envoy Medical Signs Media Deal with New to The Street

2025-12-18 (ET)

17:30:00

Envoy Medical Files to Sell Class A Common Stock

2024-11-14 (ET)

07:42:28

Envoy Medical reports Q3 EPS (37c) vs. 13c last year.

Noticias

Preguntas frecuentes sobre COCH, respondidas por Alphio AI

Envoy Medical, Inc. is a hearing health company. The Company is engaged in providing medical technologies across the hearing loss spectrum, all designed to shift the paradigm within the hearing industry and bring both providers and patients the hearing devices they require. Its hearing solutions include hearing aids, middle ear implants, bone conduction devices and cochlear implants. The bone conduction hearing device has two components: an external component and a surgically implanted fixture placed in the bone behind the ear. Its bone conduction hearing device offers amplification without ear mold in the ear. Its hearing aids are devices that amplify sound for those with mild to moderate hearing loss. Its Esteem is a fully implanted active middle ear implant designed to improve the hearing of adults diagnosed with moderate to severe sensorineural hearing loss. Cochlear implants are a solution for people with moderate-to-profound sensorineural hearing loss. It operates in the Healthcare sector (ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUP industry).

Envoy Medical Inc is a good buy right now due to its recent performance and positive outlook. The current price is $6.65, which is significantly below the analyst price targets of $2.00 and $2.50, indicating a potential upside. Additionally, the stock has shown a remarkable year-to-date change of +855.87% and a 20-day change of +921.51%, reflecting strong momentum. However, the main risk is the negative earnings per share (EPS) estimate of -0.70 for the upcoming earnings report, which could impact investor sentiment.

Comunidad

Más ↗

Aún no hay publicaciones

Regístrate o inicia sesión para participar

Artículos relacionados

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empezar a operar